Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2011-01-13 Chin Richard Director Grant or award · Stock Option +50,000 50,000
2011-01-13 Ahn Mark J Director Grant or award · Stock Option +50,000 50,000
2010-12-29 CYTRX CORP 10% owner Sale −2,593,881 $2.20 $5.7M 0
2010-12-22 CYTRX CORP 10% owner Sale −500,000 $2.65 $1.3M 2,593,881
2010-07-19 Varanasi Ramani VP Business Development Sale −5,000 $2.05 $10K 5,558
2010-07-19 Varanasi Ramani VP Business Development Grant or award +5,600 $2.04 $11K 11,158
2010-07-15 Pavco Pamela VP of Pharmaceutical Devlpmt. Grant or award +5,000 $2.38 $12K 11,377
2010-07-12 Khvorova Anastasia Chief Science Officer Grant or award +10,000 $2.23 $22K 17,506
2010-07-09 Beerman Noah D CEO and President Purchase +10,000 $2.23 $22K 15,407
2010-07-08 Varanasi Ramani VP Business Development Grant or award +5,000 $2.04 $10K 10,558
2010-06-30 CYTRX CORP 10% owner Sale −2,000,000 $2.55 $5.1M 3,093,881
2010-04-15 Varanasi Ramani VP Business Development Grant or award · Stock Option +15,000 15,000
2010-04-15 Pavco Pamela VP of Pharmaceutical Devlpmt. Grant or award · Stock Option +15,000 15,000
2010-04-15 Khvorova Anastasia Chief Science Officer Grant or award · Stock Option +15,000 15,000
2010-04-15 Andrikopoulos Konstantinos VP, Legal Grant or award · Stock Option +15,000 15,000
2010-03-31 Samarsky Dmitry VP, Technology Development Sale −4,081 $4.65 $19K 0
2010-03-26 CYTRX CORP 10% owner Sale −675,000 $5.70 $3.8M 5,093,881
2010-03-26 Hillsberg Sanford Director Sale −25,000 $5.66 $142K 6,000
2010-03-26 GALLIKER STEPHEN S Director Sale −15,000 $5.54 $83K 10,000
2010-03-02 KRIEGSMAN STEVEN A Director Grant or award · Stock Option +50,000 50,000

Page 22 of 29 · 580 trades